Standard Chemical & Pharmaceutical Co., Ltd. (1720) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Standard Chemical & Pharmaceutical Co., Ltd. (1720:TWSE), powered by AI.

Current Price
$62.70
Sector
Healthcare
What is the Standard Chemical & Pharmaceutical Co., Ltd. stock price forecast?

Standard Chemical & Pharmaceutical Co., Ltd. is currently trading at $62.70. View real-time AI analysis on Alpha Lenz.

What is Standard Chemical & Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Standard Chemical & Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Standard Chemical & Pharmaceutical Co., Ltd.'s P/E ratio?

View Standard Chemical & Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.

Standard Chemical & Pharmaceutical Co., Ltd.

TWSE · 1720
NT$62.70+0.10(+0.16%)
Ask about Standard Chemical & Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Standard Chemical & Pharmaceutical Co., Ltd.'s ROE is 15.4%. Explore profitability and growth together.

Ask for details

Company Overview

Standard Chemical & Pharmaceutical Co., Ltd. is a pivotal player within the pharmaceutical industry, focused on the development, manufacturing, and distribution of a wide array of pharmaceutical products. Established with a commitment to improving health outcomes, the company produces both active pharmaceutical ingredients (APIs) and finished dosage forms, ensuring a comprehensive approach to healthcare delivery. Notably, its product portfolio spans critical therapeutic areas such as cardiovascular, gastrointestinal, and anti-infective medicines, which are essential to global health management. Beyond its pharmaceutical production, Standard Chemical & Pharmaceutical Co., Ltd. adheres to rigorous quality control standards and embraces sustainable practices, reflecting its dedication to both innovation and environmental stewardship. The company's strategic presence in the market underscores its role in supporting healthcare systems across various regions, contributing to the availability of essential medications. By leveraging advanced research and development capabilities, Standard Chemical & Pharmaceutical Co., Ltd. strives to meet the dynamic demands of the pharmaceutical landscape, positioning itself as a key player in enhancing therapeutic access and efficacy worldwide.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$7.02BRevenue
0.00Shares Out
0Employees

Margins

41.42%Gross
27.82%EBITDA
19.37%Operating
21.56%Pre-Tax
17.88%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.27%Rev 3Yr
10.28%Rev 5Yr
6.18%Op Inc 3Yr
14.21%Op Inc 5Yr
2.86%Net Inc 3Yr
14.95%Net Inc 5Yr

Returns

10.93%ROA
15.42%ROE
13.25%ROIC

Financial Health

NT$1.83BCash & Cash Equivalents
NT$675.35MNet Debt
27.02%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Standard Chemical & Pharmaceutical Co., Ltd. (ticker: 1720) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 62.7 with a P/E ratio of -x and P/B of -x.

ROE is 15.42% and operating margin is 19.37%. Annual revenue is $7.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Standard Chemical & Pharmaceutical Co., Ltd. (1720) Stock Forecast 2026 $62.70 — Price, Financials & Analyst Targets | Alpha Lenz